Sonata Capital Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Sonata Capital Group's LLY Position: Q3 2026 in Review
Sonata Capital Group increased its Eli Lilly (LLY) stake by 0.3% in Q3 2026, buying an estimated $1.18K and bringing the position to 337 shares worth $389K. The position accounts for 0.12% of the portfolio, ranked #92.
Sonata Capital Group first reported a position in LLY in Q2 2025 and has held it in 6 quarters since. The position peaked at $404K in Q2 2026. 4,568 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Sonata Capital Group held 337 shares of Eli Lilly worth $389K as of Q3 2026.
- Sonata Capital Group bought 1 Eli Lilly share in Q3 2026, an estimated $1.18K.
- Eli Lilly made up 0.12% of Sonata Capital Group's portfolio in Q3 2026, its #92 holding.
- Sonata Capital Group first reported a position in Eli Lilly in Q2 2025 and has held it in 6 quarters since.
- Sonata Capital Group's Eli Lilly position peaked at $404K in Q2 2026.
- 4,568 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Sonata Capital Group's 13F filing for Q3 2026, filed 19 Oct 2026.